Earlier quoted context omitted.
Psychedelic psychotherapy was left as a casualty to the war on drugs.
? The war on drugs didn't prevent a massive rise in opioid medication
First of its kind study pits psilocybin against a common antidepressant
21–30 of 50 posts
Re: First of its kind study pits psilocybin against a common antidepressant
#2225 is a pretty fat dose. Seems excessive for a scientific study... I always wonder how these people running the studies choose their doses. Do we want the participants to have a smooth/pleasant trip? Or have an white knuckle, ego-obliterating flight through space? This reminds me of another study I read where participants were given 100+mg doses of liquid ketamine straight to the dome. The participants frequently k-h…
Re: First of its kind study pits psilocybin against a common antidepressant
#23Earlier quoted context omitted.
Can you explain why for those of us unfamiliar?
Well it's not actually a placebo to start with.
A different psychedelic, which is not expected to have an antidepressant effect, or a low, psychoactive but not antidepressant dose. Or known non-psychedelic antidepressants which have been placebo tested.
Re: First of its kind study pits psilocybin against a common antidepressant
#24Earlier quoted context omitted.
Psychedelic psychotherapy was left as a casualty to the war on drugs.
? The war on drugs didn't prevent a massive rise in opioid medication
Re: First of its kind study pits psilocybin against a common antidepressant
#25> While members of the psychedelic cohort received 25 milligrams of psilocybin during the sessions, considered a medium-to-heavy dose of the drug, those in the antidepressant group received 1 milligram. Such a low dose is typically provided in psychedelic studies in lieu of a placebo Doesn't seem like well-designed study.
Because a antidepressant works pretty much on its own. But when you treat with psychedelics, you have to have a very professional therapist guiding the patient, otherwise you will get all kinds of effects. (So I argue success depends very much on the therapist)
And a patient will notice, whether they just get a mushroom trip, or not. So what they did, they gave the control group 1 mg of antidepressant and told them, they are microdosing psilocybin.
Not really ideal, but how to improve?
Re: First of its kind study pits psilocybin against a common antidepressant
#26Earlier quoted context omitted.
Psychedelic psychotherapy was left as a casualty to the war on drugs.
? The war on drugs didn't prevent a massive rise in opioid medication
By contrast, psychedelics have not been used in medicine and were/are not considered “legitimate” by the medical establishment. So with legal prohibitions on actually obtaining and administering psychedelics, the War on Drugs actually did hinder psychedelics medical research.
Re: First of its kind study pits psilocybin against a common antidepressant
#27Re: First of its kind study pits psilocybin against a common antidepressant
#28Re: First of its kind study pits psilocybin against a common antidepressant
#29Earlier quoted context omitted.
Psychedelic psychotherapy was left as a casualty to the war on drugs.
? The war on drugs didn't prevent a massive rise in opioid medication
Re: First of its kind study pits psilocybin against a common antidepressant
#3025 is a pretty fat dose. Seems excessive for a scientific study... I always wonder how these people running the studies choose their doses. Do we want the participants to have a smooth/pleasant trip? Or have an white knuckle, ego-obliterating flight through space? This reminds me of another study I read where participants were given 100+mg doses of liquid ketamine straight to the dome. The participants frequently k-h…
It's definitely a 'proper trip' but you are making it seem like a DMT breakthrough amount.